JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments ...
(Reuters) -Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies, a biopharmaceutical company, ...
Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.
UScellular could be about to sell more of its licensed spectrum following big sales to T-Mobile, Verizon, and AT&T last year. First reported by Light Reading earlier this week, NexTech Wireless and ...
MVNOs use big networks but charge less. Here are the top ones and how you can use to stop overpaying major carriers.
Peak Scents has a reputation for creating healthy, nourishing beauty products — we talk about why we love its multi-action ...
Oil extended gains to hit the highest in more than four months as a fresh wave of US sanctions against Russia’s energy ...
The FDIC may open an investigation into BlackRock and demand more information from the company if it fails to make sufficient ...
Saks Fifth Avenue is known for selling luxe, chic clothing and accessories — we rounded up 12 deals to shop during its ...
Meet Harvard-trained neuroscientist, Cape Cod writer Lisa Genova, ('Still Alice,') in East Sandwich as she explores bipolar ...
When you’re warm and cozy inside, it can be natural to wonder if the animals you see outside your window this winter are ...